AzurRx BioPharma, Inc. AZRX
52-week range unavailable
- Open
- 3.38
- Prev close
- 3.45
- Mkt cap
- 3.43M
- Vol
- 629.03K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.38
- High
- 3.66
- Forward P/E
- -0.93
- Beta
- 1.51
- Short ratio
- 0.19
- Inst. own
- 5.82%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 15, 2021
- 50-d avg
- 4.94
- 200-d avg
- 7.50
- 1y target
- 16.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for AZRX has not been loaded yet. Try again in a moment.
Altman Z-Score
-9.82 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.8×
P/S 154×
P/B 0.2×
P/FCF -1.0×
EV/EBITDA 11.9×
EV/Sales 189×
FCF Yield -102.2%
Gross Margin 0.0%
Operating Margin -19540.0%
Net Margin -18078.3%
ROE -26.3%
ROIC -19.9%
ROA -13.5%
Revenue 0.0%
Operating Income 54.7%
EPS (diluted) 22.0%
Free Cash Flow 38.1%
Current Ratio 0.2×
Quick Ratio 0.2×
Debt / Equity 0.1×
Net Debt / EBITDA 2.2×
Interest Coverage 14.4×
Dividend Yield 6.0%
Payout Ratio -5.1%
Annual · latest fiscal year ends 2025-12-31